Summit Therapeutics SMMT
NASDAQ SMMT
$16.40 +0.92 (+5.94%)
As of: Sep 29, 2026 · 3:59 PM EDT

Summit Therapeutics (SMMT) Cash from Financing Activities (2017 - 2026)

Updated

Summit Therapeutics (SMMT) reported Cash from Financing Activities of $231.08 million for Q2 2026, compared with $2.22 million a year earlier.

Analysis

Summit Therapeutics (SMMT) Cash from Financing Activities (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Summit Therapeutics' Cash from Financing Activities came in at $842.51 million, up 342.4% year-over-year; for FY2025, it came in at $617.53 million, up 62.0% from FY2024.

  • Cash from Financing Activities has a five-year compound annual growth rate of 65.0% (FY2020 to FY2025).
  • By year, Cash from Financing Activities came in at $381.23 million in FY2024 (+340.7%), $86.51 million in FY2023 (-86.1%), $620.24 million in FY2022 (+696.0%) and $77.92 million in FY2021 (+54.1%).
  • Five-year quarterly Cash from Financing Activities spans a low of -$23.61 million in Q4 2024 and a high of $573.82 million in Q4 2025.
  • The high point for year-over-year Cash from Financing Activities in five years was Q1 2023 (growth of 218.1%); the low point was Q3 2023 (a decline of 99.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $3.8 million (Q1 2026), $573.82 million (Q4 2025) and $33.81 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -8.78 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -5.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 1.76 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.02 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -47.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -1.48 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 2.34 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -3.66 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -426.70 Mn
10 Summit Therapeutics 12.28 Bn 10.04 Bn - 231.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 231.08 Mn
Mar 31, 2026 3.80 Mn
Dec 31, 2025 573.82 Mn
Sep 30, 2025 33.81 Mn
Jun 30, 2025 2.22 Mn
Mar 31, 2025 7.68 Mn
Dec 31, 2024 -23.61 Mn
Sep 30, 2024 204.14 Mn
Jun 30, 2024 200.21 Mn
Mar 31, 2024 485,000.00
Dec 31, 2023 6.25 Mn
Sep 30, 2023 229,000.00
Jun 30, 2023 -80,000.00
Mar 31, 2023 80.11 Mn
Dec 31, 2022 520.06 Mn
Sep 30, 2022 75.00 Mn
Mar 31, 2022 25.19 Mn
Dec 31, 2021 1.26 Mn
Sep 30, 2021 676,000.00
Jun 30, 2021 20.08 Mn
API Access

Summit Therapeutics Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=SMMT&period=max&api_key=YOUR_API_KEY